复发性胶质瘤的治疗进展  

Advances in treatment of recurrent glioma

作　　者：库格鲁克·亚力坤 周庆九[1] Kugeluke Yalikun;ZHOU Qing-jiu(Department of Neurosurgery,The First Affiliated Hospital of Xinjiang Medical University,Urumqi 830011,China)

机构地区：[1]新疆医科大学第一附属医院神经外科,乌鲁木齐830011

出　　处：《临床神经外科杂志》2020年第5期588-591,共4页Journal of Clinical Neurosurgery

摘　　要：复发性胶质瘤的预后极差,但其最佳治疗方法仍在不断发展。然而,目前文献中还没有对胶质瘤术后复发治疗的共识。本文回顾近年的相关文献报道,分析第二次手术、化疗、放疗及其他治疗对复发性胶质瘤预后的影响,发现复发时的患者Karnofsky功能状态(KPS)评分和年龄是影响预后的重要因素,KPS评分大于70的年轻患者再次干预治疗的预后良好。故对复发性胶质瘤需要积极治疗,并且要不断研究发现更有效的新治疗方案。The prognosis of recurrent glioma is very poor,but the best treatment is still in development.However,there is no consensus on the treatment of recurrent glioma in the literature.This paper reviews the related literature in recent years,and analyzes the effects of second surgery,chemotherapy,radiotherapy and other treatments on the prognosis of recurrent glioma.It is found that Karnofsky performance status(KPS)score and age are the important factors affecting the prognosis of recurrent gliomas.The young patients with KPS score greater than 70 have a good prognosis.Therefore,recurrent gliomas need to be actively treated,and more effective new treatment should be found.

关 键 词：胶质瘤 复发 治疗 

分 类 号：R739.41[医药卫生—肿瘤]